Amid Debt Crisis, Life Science Firms Still See Vibrant European Market

Despite forecasts that the European economic crisis would result in sharp slashes in life science research funding, companies operating in the space say they are seeing no proof of such reductions.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.